Answers are grounded in this paper and cite their sources.
A 58-year-old right-handed- woman presented with a recurrent aggressive giant cell tumor in the second metacarpal 2 years after intralesional curettage and bone grafting. The patient had a palpable tumor, painful swelling on the dorsum of the hand, associated with limited second and third metacarpophalangeal joint range of motion. Radiographs and computed tomography scan of the right hand showed a metaphyseal-epiphyseal lytic expansile lesion of the second metacarpal bone with articular extension classified as Campanacci grade III. The surgical procedure was performed using an innovative 3-dimensional planning and printing technique of the second metacarpal. A custom-made implant of the second metacarpal (nonferromagnetic titanium-Osteobionix) was used. Eighteen months postoperatively, metacarpophalangeal mobility was a 5° extension deficit and 70° of flexion. The Mayo Wrist Score postoperatively was 75/100. Additional tests indicate no tumor recurrence or malignancy.
No takes yet. Share an insight, caveat, or question.
Lamas et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: